S100B Protein in Clinical Diagnostics: Assay Specificity

Clinical Chemistry

Volumn 50, Issue 1, 2004, Pages 249-251

  Heizmann, Claus W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S100B;

ARTICLE; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; ENZYME IMMUNOASSAY; LABORATORY TEST; MOLECULAR CLONING; PROTEIN DETERMINATION; PROTEIN FAMILY; RELIABILITY;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BODY FLUIDS; CROSS REACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOASSAY; NERVE GROWTH FACTORS; RECOMBINANT PROTEINS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 1642574216     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.027367     Document Type: Article

References (16)

1. Heizmann CW, Fritz G, Schäfer B. W. S100 proteins: structure, functions and pathology [Review]. Front Biosci 2002;7:d1356-68.
2. Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine [Review]. Clin Chem 2002;48:2097-104.
3. 2+-binding S100 proteins. In: Bode W, Messerschmidt A, Cygler M, eds. Handbook of metalloproteins, Vol. 3. Chichester, NY: John Wiley & Sons, 2004:in press.
4. Wolf R, Mirmohammadsadegh A, Walz M, Lysa B, Tartler U, Remus R, et al. Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. FASEB J 2003;17:1969-71.
5. 2+-binding protein family [Review]. Biometals 1998;11:383-97.
6. Tiu SC, Chan WY, Heizmann CW, Schäfer BW, Shu SY, Yew DT. Differential expression of S100B and S100A6 in the human fetal and aged cerebral cortex. Develop Brain Res 2000;119:159-68.
7. Chan WY, Xia CL, Dong DC, Heizmann CW, Yew DT. Differential expression of S100 proteins in the developing human hippocampus and temporal cortex. Microsc Res Tech 2003;60:600-13.
8. Vives V, Alonso G, Solai AC, Joubert D, Legraverend C. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice. J Comp Neurol 2003;457:404-19.
9. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides. Cell 1999;97:889-901.
10. Schmidt AM, Yan SD, Yan SF, Stern D. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-55.
11. Huttunen HJ, Kuja-Panulat J, Sorci G, Angeletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000;275:40096-105.
12. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al. Serum S100β. A noninvasive marker of blood-brain barrier function and brain lesions. Cancer 2003;97:2806-13.
13. Garbe C, Leiter U, Ellwanger U, Blaheta H-J, Meier F, Rassner G, et al. Diagnostic value and prognostic significance of protein S-100β, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription- polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 2003;97:1737-45.
14. Bánfalvi T, Udvarhelyi N, Orosz Z, Gergye M, Gilde K, Timár J. Heterogeneous S-100B protein expression patterns in malignant melanoma and association with serum protein levels. Oncology 2003;64:374-9.
15. Hauschild A, Engel G, Brenner W, Gäswer R, Mönig H, Henze E, et al. Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br J Dermatol 1999;140:1065-71.
16. Stigbrand T, Nyberg L, Ullén A, Haglid K, Sandström E, Brundell J. A new specific method for measuring S-100B in serum. Int J Biol Markers 2000;15:33-40.